Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 13.9B | 9.4B | 9.3B | 8.8B |
Cost of revenue | 11.0B | 7.2B | 7.1B | 6.8B |
Gross profit | 2.9B | 2.2B | 2.2B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.2B | 1.9B | 1.8B | 1.7B |
Other operating expenses | — | — | — | — |
Operating income | 685M | 346M | 376M | 327M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 13M | 13M | 13M | 12M |
Other income expense | -449M | 23M | 28M | 10M |
Pretax income | 223M | 356M | 391M | 325M |
Tax provision | 106M | 85M | 101M | 80M |
Net income | 117M | 273M | 291M | 246M |
Basic EPS | — | 1.3 | 1.4 | 1.1 |
Diluted EPS | — | 1.3 | 1.3 | 1.1 |
Basic average shares | — | 11.1M | 11.1M | 11.1M |
Diluted average shares | — | 11.1M | 11.2M | 11.2M |
EBITDA | 901M | 559M | 594M | 546M |
Net income from continuing op. | 117M | 273M | 291M | 246M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |